abstract |
The invention relates to compounds of formula (I): wherein R 1a, R 1b, R 1c, R 1d, R 2a, R 2b, R 2c, R 2d, R 3a, R 3b, R 4, n, j, j, o, p, q , r and X are as defined in the description and their use as modulators of 11 .beta.- hydroxysteroid dehydrogenase type 1 for the treatment of metabolic syndrome or type 2 diabetes. |